ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2370

Factors Affecting Interval Changes in Perceived Fatigue over Five Years in Patients with Rheumatoid Arthritis Compared with Osteoarthritis

Simon Stebbings1,2, Gareth Treharne3, J. Haxby Abbott4 and Andrew Gray5, 1Dunedin Hospital, Department of Rheumatology, Dunedin, New Zealand, 2Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand, 3Psychology, University of Otago, Dunedin, New Zealand, 4Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand, 5Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fatigue, longitudinal studies, Osteoarthritis, outcome measures and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Osteoarthritis – Clinical Aspects - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: In a previous cross-sectional study we noted higher fatigue levels in patients with advanced lower limb OA compared with RA, and identified differences in common outcome variables and their associations with fatigue between RA and OA groups. High levels of disability and depression correlated with fatigue in both conditions. In the current longitudinal study, we re-appraised patients in the initial cohort and assessed their fatigue levels and associated disease variables 5 years after their initial assessment in order to test the stability of these influences over time.

Methods: The original study recruited 103 patients each with RA or hip/knee OA (n=206). Of these 68 OA and 72 with RA were available for re-assessment after 5 years (n=140; 68% retention). Reasons for loss to follow-up were moving out of area, death and declining to take part. All participants were assessed for pain and fatigue using 100mm VAS scales; functional disability using the HAQ- disability index; and mood using the Hospital Anxiety and Depression Scale (HADS-Anxiety and HADS-Depression). CRP was measured in all participants and BMI calculated. In the RA group, the Disease Activity Score (DAS-28) was recorded. In the OA group, pain and disability were self-reported using the WOMAC score. Changes over time in the outcomes of interest were assessed separately for OA and RA using paired t-tests. Changes were compared between OA and RA using regression models of follow-up values adjusting for baseline values of the variable in question, along with baseline age, sex, and BMI. Similar models were used to examine the impact of joint replacement within the OA group. Correlations between change scores for all outcomes were investigated separately for OA and RA using Pearson’s correlation coefficients.

Results: There was no evidence for interval changes over 5 years in RA for any of the outcomes including DAS-28 scores (change +0.00; 95% CI -0.33, 0.33; p=0.989) whereas in OA significant reductions in severity for a number of outcomes were recorded in the OA group: HAQ decreased by 0.38 (95% CI 0.20, 0.55; p<0.001), WOMAC-total by 21.6 points (95% CI 16.1, 27.1; p<0.001), pain (VAS) decreased by 27.1 (95% CI 19.4, 34.9; p<0.001), HADS-Depression decreased by 2.0 (95% CI 1.1, 2.9; p<0.001). In the OA group, changes between all 15 pairs of outcomes were positively correlated (p<0.045) aside from VAS fatigue and HAQ (p=0.087). However, there were fewer significant correlations in the RA group. Among the OA group, 57 (84%) had interval hip/knee joint replacement. There was no evidence that this was associated with better follow-up HAQ, pain, or fatigue (all unadjusted and adjusted p≥0.090), but was associated with improvement on WOMAC total (14.0 points unadjusted, 95% CI 1.0, 26.9; p=0.035; 13.8 adjusted, 0.9, 26.6; p=0.036).

Conclusion: After 5 years a range of common disease outcomes were surprisingly stable in RA, but significant reductions in pain, fatigue, disability and total WOMAC score were noted in OA, although only this last measure was associated with joint replacement. The strongest correlates with fatigue over 5 years were anxiety and depression in both groups.


Disclosure: S. Stebbings, None; G. Treharne, None; J. H. Abbott, None; A. Gray, None.

To cite this abstract in AMA style:

Stebbings S, Treharne G, Abbott JH, Gray A. Factors Affecting Interval Changes in Perceived Fatigue over Five Years in Patients with Rheumatoid Arthritis Compared with Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/factors-affecting-interval-changes-in-perceived-fatigue-over-five-years-in-patients-with-rheumatoid-arthritis-compared-with-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-affecting-interval-changes-in-perceived-fatigue-over-five-years-in-patients-with-rheumatoid-arthritis-compared-with-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology